বুধবার, ৯ জুন, ২০১০

REAL MONEY MAKING SITE

Online Earning is one of the hot issues in the internet. Almost every people looking for this. But they don’t know how to get this. Because there are lots of money making site in the internet . But are they real !

When a user specially a new user visit a site, they often face a common question…….,will the site pay anything ?

Here I will try to discuss about some site, which are real and where you have to invest nothing. That means you are 100% risk free. Today I will describe about microworkers.

Site name : microworkers

Registration : free. no invest no bid.

Find task and submit task : after completing Registration , you will see a page like this.


Here you will have to select a task and read the task description carefully. If you think, you can do the task, then you will have to accept the task and submit the task according to buyer requirement. Then you have to wait for ½ days, whether the buyer accept the task or not. Payment will be add automatically to your account if the buyer accept the task.

Payment method : if you earn 10$, then you will withdraw money through paypal, alertpay, moneybookers.

So dear guest , if you lost time for searching real site, then I will suggest you that , don’t waste more time. just visit the site. Find a suitable task and complete it according to your suitable time.

So start today , try your luck.

রবিবার, ২ মে, ২০১০

sports news

START UR OWN BUSINESS

Its a promising chance for you to start your business and be a profitable businessman. You can earn 20$ - 3000$ per a day through this business.
BUSINESS TYPE - MLM (Multi Level Marketing) [ SINGAPORE, MALAYSIA, DUBAI etc are the MLM business based countrty....]
BUSINESS SYSTEM -
MEMBERSHIP - First of all you should become the member by 5000 tk.
AFTER BECOMING THE MEMBER YOU WILL BE PROVIDED-
A sub domain website of your own which is of 15 mb hosting. In this website you will get-
a. Advertising Centre - A place where you can advertise for any pld or new item.
b. Recruitment Center - A place where the customers can upload their CV's for a job nternatioanally
c. Download Center
d. E- Library
e. E- magazines
f. E- kitchens
Members can do courses given below TOTALLY FREE OF COST-
a. MS Office Package/Graphics Design(adobe photoshop, adobe illustrator, quark express)/PC Hardware & Maintainance
b. Web introduction & Internet
c. E- mail & web browsing
d. SPOKEN ENGLISH
e. E-services & games with LIFE TIME MEMBERSHIP (it means members can attend their classes any times of life)
CERTIFICATE - The Certificate will be provided through the ICDL (International Computer Driving License) by MICROSOFT.
COMPANY WILL PROVIDE YOU PASSWORD PROTECTED CREDIT CARD WHERE YOUR ACCOUNT BALANCE WILL BE SAVED. YOU CAN COLLECT YOUR MONEY WITHIN TWENTY FOUR HOURS.
if interested utilize this great opportunity.... to know more call @01911672682 (monir)

রবিবার, ১৩ ডিসেম্বর, ২০০৯

Skin Cancer


Skin cancer is a disease in which cancer cells grow in the tissues of the skin. There are two major groups: nonmelanoma and melanoma. Nonmelanoma skin cancers are by far the most common types of cancer, with more than 1 million new cases diagnosed annually, and most are highly curable. Melanoma is much less common, but more serious. Melanoma is highly curable in its early stages, but may spread to other parts of the body.
At Ohio State's Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, we have skin cancer experts who have dedicated their lives to providing the best skin cancer research and treatment. With research and treatment areas under one roof, we are better able to apply research advances to patient care. Recent research advancements include:
• A laboratory study led by Anne VanBuskirk, PhD, OSUCCC Immunology Program, to find immunological approaches to help organ transplant patients fight skin cancer, a disease to which they are highly susceptible.
• Clinical trials directed by William Carson, MD, a surgical oncologist at The James and leader of the OSUCCC Immunology Program, based on immunology and the promise of a “vaccine” to help slow or stop the growth of malignant melanoma.
• A study examining the use of a newly developed, molecularly targeted drug designed to inhibit key cancer growth factors. Interim results suggest the drug may be helpful in controlling malignant melanoma, which typically responds poorly to traditional treatments with chemotherapy or radiation.
• Studies found that a popular treatment for skin cancer, the topical chemotherapeutic agent 5-flurouracil (5-FU), could be made much more effective by adding celecoxib, a popular non-steroidal anti-inflammatory drug for pain.

শনিবার, ১২ ডিসেম্বর, ২০০৯

Lung Cancer


Lung cancer is cancer that begins in the lungs. It is the leading cause of cancer deaths in both men and women, although the survival rate has improved slightly in recent years. Cigarette smoking is the most common risk factor for lung cancer, with almost 90 percent of all lung cancers attributable to smoking or secondhand exposure to cigarette smoke.
The lung cancer experts at The James have dedicated their lives to supporting and caring for cancer patients and their families, and our specialized team approach provides the best cancer research and treatment. Physicians and researchers at Ohio State's Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute are continually seeking new answers to questions about lung cancer. Recent research advancements include:
• An $8 million award from Ohio's Third Frontier program to launch a massive effort to better prevent, detect and treat lung cancer. The award is expected to attract an additional $13.5 million from the project's commercial partners, helping to position Ohio as an international leader in innovative strategies and technologies in fighting the world's deadliest malignancy. Read more...
• Studies led by Miguel Villalona, MD, that address the selection of systemic therapy according to molecular changes in tumors – an approach considered by some scientists to be the “holy grail” for advanced metastatic lung cancer. Read more...
• Gregory Otterson, MD, is leading a multi-institutional study of inhalation chemotherapy for previously untreated, advanced non-small cell lung cancer.
Surgical resection remains a mainstay of therapy for early-stage non-small cell lung cancer; however, multimodality therapy utilizing chemotherapy and radiation therapy has become an increasingly important part of all treatment plans. Combining innovative therapies, such as photodynamic therapy and radio frequency ablation, with other forms of intervention, such as chemotherapy, has enabled our team to offer surgery to a larger percentage of patients. In fact, this includes patients who previously may have been considered unresectable.
The lung cancer team at The James has been at the forefront of initiatives to combine multiple treatment modalities to optimize a treatment plan for each patient.
• Under the direction of Patrick Ross, MD, PhD, the photodynamic program at Ohio State has grown to one of the leading centers in the country. Photodynamic therapy is used for curative, palliative and combined modality treatments in lung cancer. Ohio State continues to use this innovative technology in new and exciting ways.
• As a center with expertise in treating end-stage lung disease (lung volume reduction surgery and lung transplantation), the team at Ohio State has been able to treat lung cancer patients. Many patients whose lung disease is so severe that they would have been excluded from surgery have been optimized by medical management and smoothly brought through lung resections.

শুক্রবার, ১১ ডিসেম্বর, ২০০৯

Breast Cancer


Breast cancer, a disease in which malignant cells form in the tissues of the breast, is the most common type of cancer (other than skin cancer) among women. Less than 1 percent of breast cancers occur in men. The risk of getting breast cancer increases with age, and inherited gene mutations or a family history of breast cancer may increase the risk.
At Ohio State's Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, our breast cancer experts deliver excellent patient care in a research context. Our Comprehensive Breast Health Services (CBHS) facility in Dublin, Ohio, about 20 minutes from The James and the main Ohio State campus, evaluates and treats more than 500 breast cancer patients annually.
CBHS medical, surgical, and radiation oncologists are specialists in breast cancer. CBHS Co-Directors Charles Shapiro, MD, and William Farrar, MD, are nationally recognized by their peers as being among the “Best Doctors in America,” “Top Doctors in America,” and the “Best Cancer Doctors in America.”
Physicians and researchers at the OSUCCC – James work together to make important discoveries that establish new approaches to breast cancer. Examples include:
• William Carson, MD: Making standard therapies work better by enhancing the immune system IL-12, herceptin, paclitaxel
• Pravin Kaumaya, PhD: HER2 peptide vaccine
• Barbara Andersen, PhD: Stress and immunity project that evaluates the effect of stress on immune function in breast cancer survivors
• Electra Paskett, PhD, MsPH: Lymphedema and other survivorship issues in breast cancer survivors
• Charles Shapiro, MD: Osteoporosis in young women with breast cancer; incorporating biologic agents in combination with known breast cancer chemotherapy drugs (paclitaxel and bortezumab, paclitaxel and suramin, docetaxel and bevacizumab)
• Richard Love, MD: Effects of ovarian ablation in breast cancer

বুধবার, ৯ ডিসেম্বর, ২০০৯

Brain Cancer


Brain cancer, or a primary brain tumor, is a cancer that begins in the tissues of the brain. It rarely spreads to other parts of the body, although if not treated, it will grow and the symptoms will worsen over time. Brain cancer is a leading cause of cancer-related deaths, but research has produced new, more effective treatment methods. Surgery, radiation and chemotherapy are the most commonly used treatments.
Our multidisciplinary brain and spine neuro-oncology clinic at The James brings together a team of expert physicians to provide patients the benefit of the latest knowledge and techniques in related areas of specialization.
A fund established by the Ohio Supreme Court to further cancer research has provided support for the Dardinger Family Endowed Chair in Oncological Neurosurgery held by E. Antonio Chiocca, MD, PhD, and the Esther Dardinger Endowed Chair in Neuro-Oncology held by Herbert Newton, MD, as well as the opening of the Dardinger Neuro-Oncology Center at Ohio State's James Cancer Hospital and Solove Research Institute. Co-directed by Chiocca and Newton, the Center is devoted to research and treatment of cancer affecting the central nervous system. In addition, more than $1.5 million per year has been awarded by the National Institutes of Health to Dr. Chiocca and his research group to study the biology of this cancer and find new treatments.
With research and treatment areas under one roof at the OSU Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, we are able to better facilitate translational research and the application of research advances to patient care. For example:
• Patients whose brain tumors were once considered inoperable can now benefit from stereotactic radiosurgery, a non-invasive technique offered by The James that delivers high-dose radiation to a precisely targeted area while sparing healthy tissue. The procedure has low risk, is cost effective and requires only a short hospital stay.
• Gamma knife surgery is a stereotactic radiosurgery technique used to treat people with brain cancer and other neurological disorders. With this specialized radiation machine, 201 tiny, Cobalt60 radioactive sources precisely direct radiation beams, which all converge in one spot. Complex computer computations are carried out to create an individualized treatment plan for each patient and each tumor. The procedure has been used to treat nearly 80,000 individuals to date. The James is one of the only central Ohio facilities that offers gamma knife surgery.
• Through the use of intra-operative magnetic resonance imaging (MRI) and a global positioning system (GPS) in the operating room, OSUCCC-James surgeons are able to remove brain tumors with greater efficiency and less risk. This technology enables the surgeons to operate while patients are anesthetized, but awake, which is especially effective in helping to preserve patients’ speech functions.
• Physicians at The James may also use Peacock Stereotactic Radiotherapy, a radiation treatment method that helps focus treatment precisely to a selected area. The Peacock system is able to hold the head very still, then guide and shape the radiation that destroys the tumor. The dose of radiation is carefully planned to be a safe amount in the right place. Aiming the radiation only at the tumor helps protect other important nerves and areas of the brain.
• New research at the OSUCCC-James shows than an oncolytic virus (a virus that kills cancer cells) can increase the survival of mice with an incurable human brain tumor. Chiocca says this was a preliminary study, but he believes oncolytic viruses offer a promising new strategy. His collaborators included Yoshinaga Saeki, MD, PhD, chief of the Dardinger Laboratory for Neuro-Oncology and Neurosciences, and post-doctoral fellow Hirokazu Kambara, PhD.
• New clinical trials using molecular and conventional forms of chemotherapy are under development and will use drugs such as erlotinib, sunitinib, AQ4N, AZD2171, and dose-intensive temozolomide. Under the direction of Herbert Newton, MD, and Robert Cavaliere, MD, these protocols will become an important clinical resource for brain tumor patients in Ohio and the upper Midwest.